Dosage Regimen Optimization of Ertapenem Against ESBL ‐Producing Enterobacterales Infection in Critically Ill Patients Using Monte Carlo Simulation

Documenti analoghi

• Population Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy: Influence of Adsorptive Membranes
  di: Chidtawan Hirunsomboon, et al.
  Pubblicazione: (2026)
• Mortality factors and antibiotic options in carbapenem‐resistant Enterobacterales bloodstream infections: Insights from a high‐prevalence setting with co‐occurring NDM‐1 and OXA‐48
  di: Palat Karnmueng, et al.
  Pubblicazione: (2024)
• Efficacy, safety, and pharmacokinetics of isoniazid affected by NAT2 polymorphisms in patients with tuberculosis: A systematic review
  di: Thanakorn Surarak, et al.
  Pubblicazione: (2024)
• Population Pharmacokinetics and Pharmacodynamics of Sitafloxacin in Plasma and Alveolar Epithelial Lining Fluid of Critically Ill Thai Patients With Pneumonia
  di: Taniya Paiboonvong, et al.
  Pubblicazione: (2025)
• Ertapenem in the Context of Hypoalbuminemia: Implications for Critically Ill Patients
  di: Micaela Elene Seazzu, et al.
  Pubblicazione: (2025)